January 22, 2013 – By now, women taking the birth control drugs Yaz or Yasmin are used to warnings that the drugs may increase the risk for blood clots. However, those women who also suffer from migraine headaches should take notice of new research which shows they may be at an even higher risk than others.
For several years, drug experts from the FDA to the British Medical Journal to the New England Journal of Medicine have reported studies showing birth control drugs which contain drospirenone, like Yaz and Yasmin, may carry as much as a 74% higher risk of blood clots.
While clots are a natural defense of the body, they may also be very dangerous in unintended circumstances, causing serious or fatal conditions like stroke, pulmonary embolism or deep-vein thrombosis.
Earlier this month, the Health Ministry of France made news when they announced they will stop reimbursing for drugs like Yaz which contain drospirenone in March, over these health concerns.
Now, researchers from Brigham and Women’s Faulkner Hospital in Boston have announced new findings which show that, while combined hormone contraceptives like Yaz and Yasmin may raise blood clot risks for all women, the risks are significantly higher for those suffering migraines.*
Due to the failure of Bayer to properly warn of the dangers of their popular birth controls, thousands of those affected by blood clots have already filed Yaz lawsuits. The massive litigation has been moved to a special Multi-District Litigation court in Illinois.
Last year, Bayer announced they had begun settling many of these cases. In their last financial report, they disclose spending almost $750 million to settle around 3,500 Yaz lawsuits for blood clot injuries. That would amount to an average of approximately $214,000 per case. The company has also set aside additional funds for other victims.
If you or a loved one suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin, it is important to speak with a lawyer about your legal options. The time to file a claim may be limited.
DrugRisk cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz, or to speak with a lawyer, contact us today.